Mohammed Khadeer - Concepedia

Author

Mohammed Khadeer

Also Known As

M A Khadeer, M Khadeer, M. A. Khadeer, M.A Khadeer, M.A. Khadeer, Mohammed A Khadeer, Mohammed A. Khadeer, Mohammed Abdul Khadeer, Mohammed Khadeer

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

National Institute on Aging National Institutes of Health Johns Hopkins University Johns Hopkins Medicine University of Maryland, Baltimore

About

Mohammed Khadeer is an author at National Institute on Aging specializing in medicine, cell biology, and cellular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	560
2	Natural Sciences	3	3	64
3	Health Sciences	2	2	151
4	Biochemistry	2	2	43
5	Public Health	1	1	25

Mohammed Khadeer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Child Stunting is Associated with Low Circulating Essential Amino Acids Richard D. Semba, Michelle Shardell, Fayrouz A Sakr Ashour, EBioMedicine	2016	334
(R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin Function Rajib Paul, N. Singh, Mohammed Khadeer, Anesthesiology	2014	113
Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study Rengappa Ramakrishnan, M. Jayahar Bharathi, C Shivkumar, Eye Ocular DiseaseOphthalmology10-Year Retrospective StudyPathogenesisMicrobiological Profile	2008	105
Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging Ruin Moaddel, Elisa Fabbri, Mohammed Khadeer, The Journals of Gerontology Series A	2016	99
Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells Zhihui Tang, Surasri N. Sahu, Mohammed Khadeer, Bone Tissue EngineeringRegenerative MedicineZip1 Zinc TransporterMesenchymal Stem CellsDevelopmental Biology	2005	84
Kynurenines link chronic inflammation to functional decline and physical frailty Reyhan Westbrook, Tae Chung, Jacqueline Lovett, JCI Insight AgingImmunologyCell DeathOxidative StressNeuroinflammation	2020	84
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects Ruin Moaddel, Michelle Shardell, Mohammed Khadeer, Psychopharmacology PsychiatryMedicinePsychotropic MedicationPlasma Metabolomic ProfilingMetabolomic Profiling	2018	83
Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging Marta González‐Freire, Ruin Moaddel, Kai Sun, The Journals of Gerontology Series A	2018	69
Identification of the type II Na+-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2−/− mice Akshara Gupta, Harriet S. Tenenhouse, Hannah M. Hoag, Bone MechanobiologyMolecular PhysiologyNpt2−/− MicePhysiologySkeletal Biology	2001	67
Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of Aging Richard D. Semba, Pingbo Zhang, Fatemeh Adelnia, Aging Cell	2019	67

Page 1